Aztreonam is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Aztreonam.
| Product ID | 63323-401_302fd27d-0a22-44ea-91fb-1b1ffcf17a1f |
| NDC | 63323-401 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Aztreonam |
| Generic Name | Aztreonam |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2009-11-05 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA065439 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | AZTREONAM |
| Active Ingredient Strength | 1 g/1 |
| Pharm Classes | Monobactam Antibacterial [EPC],Monobactams [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2009-11-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA065439 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-11-05 |
| Marketing Category | ANDA |
| Application Number | ANDA065439 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-11-05 |
| Marketing Category | ANDA |
| Application Number | ANDA065439 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-11-05 |
| Ingredient | Strength |
|---|---|
| AZTREONAM | 1 g/1 |
| SPL SET ID: | 5f5ebb63-6ac5-4fb4-bcc1-d069c123eb18 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-0829 | Aztreonam | Aztreonam |
| 0409-0830 | Aztreonam | Aztreonam |
| 63323-401 | Aztreonam | AZTREONAM |
| 63323-402 | Aztreonam | AZTREONAM |
| 0003-2230 | AZACTAM | AZTREONAM |
| 0003-2240 | AZACTAM | AZTREONAM |
| 0003-2560 | AZACTAM | AZTREONAM |
| 0003-2570 | AZACTAM | AZTREONAM |
| 61958-0901 | Cayston | aztreonam |